CannaPharmaRX, Inc. (CPMD)
OTCMKTS
· Delayed Price · Currency is USD
0.0049
+0.0016 (48.48%)
May 23, 2025, 10:43 AM EDT
CannaPharmaRX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1.13 | 0.82 | - | - | - | - | Upgrade
|
| Cost of Revenue | 4.15 | 3.78 | 0.07 | 0.03 | - | - | Upgrade
|
| Gross Profit | -3.02 | -2.96 | -0.07 | -0.03 | - | - | Upgrade
|
| Selling, General & Admin | 0.43 | 0.6 | 1.28 | 4.6 | 2.25 | 3.69 | Upgrade
|
| Other Operating Expenses | 0.05 | 0.05 | 0.1 | 0.1 | - | - | Upgrade
|
| Operating Expenses | 0.46 | 0.65 | 1.51 | 5.18 | 2.62 | 4.64 | Upgrade
|
| Operating Income | -3.48 | -3.61 | -1.58 | -5.21 | -2.62 | -4.64 | Upgrade
|
| Interest Expense | -2.3 | -2.27 | -1.7 | -2.29 | -1.51 | -2.29 | Upgrade
|
| Other Non Operating Income (Expenses) | 8 | -3.34 | 0.15 | -0.1 | 3.17 | -3.68 | Upgrade
|
| EBT Excluding Unusual Items | 2.21 | -9.22 | -3.13 | -7.6 | -0.95 | -10.61 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.38 | -1.89 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -7.96 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.28 | - | -0.08 | - | -6.67 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.62 | - | Upgrade
|
| Other Unusual Items | -1.37 | -0.69 | 6.89 | -0.93 | -1.45 | 0.57 | Upgrade
|
| Pretax Income | 1.12 | -9.91 | 3.69 | -8.53 | -8.83 | -19.89 | Upgrade
|
| Net Income | 1.12 | -9.91 | 3.69 | -8.53 | -8.83 | -19.89 | Upgrade
|
| Net Income to Common | 1.12 | -9.91 | 3.69 | -8.53 | -8.83 | -19.89 | Upgrade
|
| Shares Outstanding (Basic) | 703 | 625 | 309 | 211 | 75 | 41 | Upgrade
|
| Shares Outstanding (Diluted) | 703 | 625 | 309 | 211 | 75 | 41 | Upgrade
|
| Shares Change (YoY) | 117.50% | 102.40% | 46.38% | 182.57% | 83.50% | 30.55% | Upgrade
|
| EPS (Basic) | 0.00 | -0.02 | 0.01 | -0.04 | -0.12 | -0.49 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.02 | 0.01 | -0.04 | -0.12 | -0.49 | Upgrade
|
| Free Cash Flow | -1.75 | -1.7 | -2.36 | -1.56 | -2.42 | -0.56 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.03 | -0.01 | Upgrade
|
| Operating Margin | -308.31% | -439.59% | - | - | - | - | Upgrade
|
| Profit Margin | 99.08% | -1207.82% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -154.90% | -206.94% | - | - | - | - | Upgrade
|
| EBITDA | -3.38 | -3.48 | -1.45 | -4.91 | -2.61 | -4.51 | Upgrade
|
| D&A For EBITDA | 0.1 | 0.13 | 0.13 | 0.29 | 0 | 0.13 | Upgrade
|
| EBIT | -3.48 | -3.61 | -1.58 | -5.21 | -2.62 | -4.64 | Upgrade
|
| Advertising Expenses | - | - | 0.03 | 0.3 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.